Valuation : BioGaia AB

Market Cap 11.12B 1.16B 996M 938M 855M 1.6B 110B 1.61B 4.3B 56.13B 4.35B 4.25B 178B P/E 2026 *
28.7x
P/E 2027 * 23.4x
Enterprise Value 10.45B 1.09B 936M 882M 803M 1.5B 104B 1.51B 4.04B 52.76B 4.09B 4B 167B EV / Sales 2026 *
6.26x
EV / Sales 2027 * 5.58x
Free-Float
80.82%
Yield 2026 *
2.68%
Yield 2027 * 2.91%
1 day-1.64%
1 week-3.14%
Current month-5.84%
1 month-4.00%
3 months-13.60%
6 months-3.23%
Current year+1.69%
1 week 108
Extreme 108
113.5
1 month 108
Extreme 108
117.8
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 2023-09-29
Director of Finance/CFO 59 2019-11-04
Chief Operating Officer 49 2020-12-31
Director TitleAgeSince
Chairman 77 2002-12-31
Chairman 76 2018-04-24
Director/Board Member 46 2014-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/13/26 Buy

Director

582 0.0006%
12/30/25 Buy

General Counsel

390 0.0004%
12/5/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-3.14%+4.75%+12.32% 1.16B
-1.46%-4.96%+44.22%-3.83% 80.65B
-1.00%-3.42%-19.64%-36.89% 59.12B
-1.10%-9.22%+455.94%+27.74% 54.14B
+0.83%-3.26%-9.28%+30.44% 50.1B
-1.08%-8.25%-2.83%+145.69% 45.33B
+2.28%-4.32%+50.63%-17.03% 31.14B
-0.17%-1.66%+45.95%+95.44% 25.54B
-3.92%-8.04%-5.27%+146.34% 21.8B
-0.32%-4.13%+63.70%+98.83% 16.06B
Average -0.69%-3.72%+62.82%+49.91% 38.5B
Weighted average by Cap. -0.61%-3.85%+78.33%+35.95%

Financials

2026 *2027 *
Net sales 1.67B 174M 150M 141M 128M 240M 16.54B 241M 645M 8.43B 653M 639M 26.7B 1.88B 195M 168M 158M 144M 270M 18.59B 271M 725M 9.47B 734M 718M 30.01B
Net income 387M 40.3M 34.68M 32.65M 29.75M 55.67M 3.83B 55.89M 150M 1.95B 151M 148M 6.19B 474M 49.36M 42.47M 39.99M 36.44M 68.18M 4.7B 68.45M 183M 2.39B 185M 181M 7.58B
Net Debt -667M -69.46M -59.77M -56.28M -51.28M -95.94M -6.61B -96.33M -258M -3.37B -261M -255M -10.67B -646M -67.22M -57.84M -54.46M -49.63M -92.85M -6.4B -93.22M -249M -3.26B -252M -247M -10.32B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
26-09-10 SEK 108.00 -1.73% 59,412
26-09-09 SEK 109.90 -0.45% 104,818
26-09-08 SEK 110.40 -0.72% 104,616
26-09-07 SEK 111.20 -1.94% 130,472
26-09-04 SEK 113.40 +1.70% 118,962
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
109.90SEK
Average target price
152.50SEK
Spread / Average Target
+38.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!